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T
he yeast vacuole (similar to the 
lysosome in higher eukaryotes) is 
the recipient of cargo from both 
the secretory and endocytic pathways. 
Studies of this highly dynamic organelle 
have been crucial to our general under-
standing of intracellular transport, and 
Christian Ungermann continues to eluci-
date the many different steps of vacuole 
fusion and the proteins that regulate them.
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University of Tübingen, Ungermann 
earned his PhD with Walter Neupert and 
discovered that the molecular chaperone 
Hsp-70 drives mitochondrial protein im-
port (1). As a postdoc in Bill Wickner’s 
laboratory at Dartmouth Medical School, 
he switched his attention to the vacuole, 
helping to defi  ne the key sequential steps 
of membrane fusion: priming, tethering, 
and docking (2, 3). He’s continued on this 
path as a group leader, fi  rst in Heidelberg 
and now as a full profes-
sor at the University of 
Osnabrück, recently dis-
covering a new tethering 
complex called CORVET 
that, along with the HOPS 
complex, regulates traffi  c 
between the vacuole and 
endosomes (4). These 
multi-subunit complexes 
form the initial contact be-
tween membranes, acting 
as downstream effectors of small GTPases 
called rabs. In addition, his laboratory 
is interested in the regulation of vacuole 
fusion by post-translational modifi  ca-
tions, including phosphorylation and 
palmitoylation (5, 6).
In a recent interview, Ungermann spoke 
about his career, the power of yeast in un-
derstanding cell biology, and which steps of 
membrane fusion will be dissected next.
LOOKING FOR THE ANSWERS
When did your interest in science begin?
I think it started toward the end of high 
school, when I was generally interested in 
biology, but wasn’t satisfi  ed with the simple 
answers I got. I decided to move more into 
the fi  eld of biochemistry, and there it started 
to become really interesting. So initially I 
was like lots of children who were just inter-
ested in biology as a phenomenon.
At which point in your studies did you 
realize that research was for you?
I was always blessed with being quick at 
doing experiments, and I really enjoyed 
having hands-on experience. But it was re-
ally when I went to the US, for a master’s 
degree at Oregon State University. I went 
over with an exchange program and was 
then exposed to the rather research-orient-
ed American system. We were confronted 
with lots of papers that we had to read and 
assignments to write, and we had to ex-
plore the literature in a lot more detail. 
That was far beyond what I did before.
What made you choose Walter 
Neupert’s laboratory for your PhD?
When I was looking for PhD positions, 
my girlfriend—now my wife—and I de-
cided that we would like to go back to 
Germany after being in the US for two 
years. I was always fascinated about mito-
chondria and mitochondrial import.
This was before the Internet was really 
present, so you had to go to the library, look 
at papers, look at records, and try to fi  gure 
out whether this is something for you.
That must have been a lot of work 
compared with how it is nowadays.
It’s kind of diffi  cult to describe to people 
who haven’t had this experience! One of 
the things I was completely excited about 
was that the Neupert laboratory could re-
constitute a system of transportation from 
purifi  ed organelles and purifi  ed compo-
nents. I found this very appealing.
SWITCHING CONTINENTS, TOPICS
Were you tempted to stay with mito-
chondrial import for your postdoc?
Yes, I thought about it. When you leave 
the laboratory you always think every-
thing is explored, and then you look at the 
mitochondrial literature ten years later, 
and they found out so many more compo-
nents and pathways! You can never pre-
dict how a fi  eld evolves.
But I always switch a little bit in my in-
terests. I became more and more fascinated 
with vesicle fusion at that time, through the 
talks I listened to during my PhD. So even 
though I found mitochondrial import very 
exciting, I felt that this was actually the di-
rection that would be fruitful for me. The 
vesicular transport fi  eld was really explod-
ing. Randy Schekman and Jim Rothman 
had already explored the basic biochemis-
try and the genes involved.
This is around the time when SNARE 
proteins were ﬁ  rst suggested to control 
membrane fusion?
Yes, that came up in 1993, and was further 
looked at in ’94, and there was a sort of ta-
pering off period where people didn’t really 
progress much beyond the initial observa-
tions. Then the vacuole fusion fi  eld showed 
up and suddenly there was a system that 
was accessible where you could target the 
components again. With mitochondria you 
had purifi  ed organelles that you could work 
with and manipulate, and I felt that vacu-
oles were a similarly attractive system.
Christian Ungermann dissects the many steps involved in membrane trafﬁ  cking.
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Did you think of staying in the US after 
your postdoc?
Yes. It looks like I’m switching between 
continents continuously! Bill Wickner of-
fered to support me in applying to the 
American academic communities. But, 
for me I felt like I was more European, 
that this was my cultural home. I thought 
about it for a little while, but we had three 
children—twin girls and a son—and so 
we felt that, for us, the better choice was 
to go back to Germany.
How would you compare the academic 
systems in the US and Germany?
The German system doesn’t have a ten-
ure track, but it’s slowly evolving. In-
stead Germany has a habilitation system, 
in which basically you have to summa-
rize the research that you’ve done up to a 
certain point, and you have to defend it 
against an audience of scientists. Also, 
you have to show that you have done 
enough teaching. In most cases we have 
to reapply for a position, and it’s rarely 
the case that it’s at the same university. 
Most of the time you have to move. So I 
guess that’s the main difference from the 
US system. In the US, you have a very 
low teaching obligation initially, and you 
have the tenure system.
How do you manage to balance your 
teaching and research responsibilities?
It’s always a matter of juggling. You try 
to do it as best as you can, and it works 
out, I have to say. It’s also an enjoyable 
part of my position: to interact with 
young students and talk to them about 
science, and try to give them some ide-
as. I feel that this is actually also train-
ing me because I have to go back and 
explore the things that I do in the labo-
ratory and see how they compare to 
what I teach.
And you’re a father, so how do you 
balance family and research?
There’s a certain limitation of time, but 
we do lots of things as a family, like rock 
climbing, skiing, and hiking. We go to the 
theater and movies, like everyone else. 
My children were born in the fi  rst year of 
my PhD. I think it’s possible to balance 
the two. There’s nothing that excludes it. 
But I had the advantage that my wife took 
a good part of the child-raising work on 
her shoulders. Otherwise, I wouldn’t have 
had the chance to work at this level, and at 
this intensity.
THE POWER OF YEAST
As a model organism, are yeast as 
useful now as they ever have been?
I think people tend to question this to 
some degree now, but if you consider 
that more than 90% of genes are the 
same between human and yeast, it’s ba-
sically a question of which system is 
best to address your specifi  c scientifi  c 
question. Working with the HOPS and 
CORVET complexes, these genes are 
conserved, and we have much better 
access to addressing their specifi  c func-
tion in yeast, since we can purify the 
different complexes.
We also have the advantage of not hav-
ing so many isoforms that can compen-
sate for each other. The complexity is 
greater if you go to a higher eukaryote.
So it’s the combination of good genetics 
and good biochemistry?
I suppose that is the advantage. It’s al-
ways pleasing and surprising at the same 
time to see that a lot of fundamental 
processes—be it the endocytic pathway 
or the cell cycle—are conserved across 
eukaryotes. For the questions that we ad-
dress, we feel that yeast is ideal, since it 
provides us with a very nice assay sys-
tem, which in mammalian cells actually 
becomes more tricky.
<ID>jcb.1843pi1fig2.eps</ID>What are you working on at the moment?
We’re trying to dissect the CORVET 
complex and really get an idea of how 
the initial steps of mem-
brane fusion are work-
ing. We believe that the 
CORVET, like the HOPS 
complex, combines a few 
activities. One activity is 
certainly effector func-
tion for the endosomal 
rab GTPase, Vps21. In 
addition, it should in-
clude a nucleotide ex-
change function to acti-
vate the rab to begin 
with. And we would ex-
pect that it has an ability 
to bind a SNARE as well, 
so that it can regulate 
downstream fusion events. We’re trying 
to dissect these different steps.
We’re also trying to look more at the 
enzymatic mechanism of protein palmi-
toylation as a regulatory step in fusion. 
It’s actually surprising that the substrate 
specifi  city of the palmitoylation machin-
ery is rather low—it can actually modify a 
lot of proteins. We also don’t know how 
the palmitate is lost. People have suggest-
ed it might be done by thioesterases, but 
at least the yeast protein can be deleted 
without much of an effect. Maybe the 
mechanism is a lot different to what we’ve 
been thinking. 
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The endosomal protein Vps21 (green), is 
concentrated close to the vacuole (red) when 
a tethering protein is overexpressed.
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